Colloidal bismuth subcitrate (DE-NOL) and tinidazole healed duodenal ulceration with a low relapse rate due to elimination of Campylobacter pylori.
Goodwin
C S
CS
Department of Microbiology, Gastroenterology, and Pathology, Royal Perth Hospital, PO box X2213, Perth, Western, Australia.
Marshall
B J
BJ
Blackbourn
S J
SJ
Warren
J R
JR
Phillips
M
M
D000890:Anti-Infective Agents / Q000627:therapeutic use*; D000897:Anti-Ulcer Agents / Q000627:therapeutic use*; D000994:Antitrichomonal Agents / Q000627:therapeutic use*; D002169:Campylobacter Infections / Q000188:drug therapy*; D002927:Cimetidine / Q000627:therapeutic use; D002986:Clinical Trials as Topic; D003102:Colloids; D004381:Duodenal Ulcer / Q000188:drug therapy* / Q000382:microbiology; D016480:Helicobacter pylori; D006801:Humans; D009942:Organometallic Compounds / Q000627:therapeutic use*; D014011:Tinidazole / Q000627:therapeutic use*; D016896:Treatment Outcome
D000890:Anti-Infective Agents; D000897:Anti-Ulcer Agents; D000994:Antitrichomonal Agents; D003102:Colloids; D009942:Organometallic Compounds; D014011:Tinidazole; D002927:Cimetidine; C002791:bismuth tripotassium dicitrate